EASL Clinical Practice Guidelines on the management of cystic liver diseases

J Drenth, T Barten, H Hartog, F Nevens, R Taubert… - Journal of …, 2022 - Elsevier
The advent of enhanced radiological imaging techniques has facilitated the diagnosis of
cystic liver lesions. Concomitantly, the evidence base supporting the management of these …

Pansomatostatin agonist pasireotide long-acting release for patients with autosomal dominant polycystic kidney or liver disease with severe liver involvement: a …

MC Hogan, JA Chamberlin, LE Vaughan… - Clinical Journal of the …, 2020 - journals.lww.com
Results Of 48 subjects randomized, 41 completed total liver volume measurements (n= 29
pasireotide long-acting release and n= 12 placebo). From baseline, there were− 99±189 …

Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework

R Duijzer, LHP Bernts, A Geerts, B van Hoek… - The Lancet …, 2024 - thelancet.com
Liver cyst infections often necessitate long-term hospital admission and are associated with
considerable morbidity and mortality. We conducted a modified Delphi study to reach expert …

Efficacy of Prolonged Antibiotic Therapy for Renal Cyst Infections in Polycystic Kidney Disease

J Dang, A Scemla, C Loheac, A Chaba… - Mayo Clinic …, 2022 - Elsevier
Objective To determine the impact of antibiotic therapy (ATBT) on outcomes of renal cyst
infection (CyI) in patients with polycystic kidney disease. Patients and Methods We …

Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case …

LHP Bernts, SEI Dekker, D Soonawala… - Journal of …, 2020 - academic.oup.com
Background Hepatic cyst infection is a complication of polycystic liver disease (PLD) that
causes substantial morbidity. Repetitive infection is frequent and is increasingly difficult to …

Preliminary analysis of clinical effect observation and prognostic recurrence factors of ultrasound-guided sclerotherapy of renal and hepatic cysts

L Li, J Luo, H Lu - International Journal of Radiation Research, 2023 - search.proquest.com
Background: To investigate the difference in the effect of ultrasound-guided puncture
injection of polidocanol (PO) and ethanol (ET) in the treatment of renal and hepatic cysts …

Ciprofloxacin penetration into infected hepatic cysts in autosomal dominant polycystic kidney disease: a case report

LHP Bernts, E Wallenburg… - Journal of …, 2019 - academic.oup.com
Sir, Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the
presence of multiple cysts residing in the kidneys and liver. ADPKD may be complicated by …

多囊肾囊内感染与肾移植.

黎雪琳, 苗芸 - Organ Transplantation/Qi Guan Yi Zhi, 2021 - search.ebscohost.com
常染色体显性多囊肾病(ADPKD) 是一种常见的单基因遗传性肾病, 可进展为终末期肾病(ESRD).
ADPKD 患者常反复发生囊内感染, 抗生素治疗所产生的耐药性问题日益突出 …

Modellierung des Krankheitsverlaufes der polyzystischen Lebererkrankung unter Verwendung altersangepasster Lebervolumina und gezielter Mutationsanalysen

D Sierks - ul.qucosa.de
Abstract (DE) Die polyzystische Lebererkrankung (PLD) ist eine sehr variable Erkrankung,
die asymptomatisch oder schwerwiegend sein kann. Allerdings ist es derzeit schwierig …

[PDF][PDF] RECURRENT HEPATIC CYST INFECTIONS IN POLYCYSTIC LIVER DISEASE: A RETROSPECTIVE CASE SERIES

LHP Bernts, SEI Dekker, D Soonawala… - MANAGEMENT OF … - repository.ubn.ru.nl
Background Hepatic cyst infection is a complication of polycystic liver disease (PLD) that
causes substantial morbidity. Repetitive infection is frequent and is increasingly difficult to …